タイログロブリン遺伝子ポイント変異は,非流行性単純な臓と関連しています
関連する実験動画
Updated: Aug 5, 2026

06:33
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
1Departamento de Medicina-Unidad de Genética Molecular, Universidad de Salamanca, Spain.
Lancet (London, England)
|February 20, 1993
まとめ
研究者らは,非流行性単純な腸症に関連したチログロブリン遺伝子の特定の変異を特定しました. 甲状腺代謝におけるこの遺伝的欠陥は,甲状腺拡張障害のいくつかの症例を説明する可能性があります.
科学分野:
- エンドクリノロジー エンドクリノロジー
- 人間の遺伝学 人間の遺伝学
- 分子生物学は分子生物学である.
背景:
- 甲状腺の拡大である単純なは,しばしば原因が不明である.
- 甲状腺代謝のタンパク質の欠陥との発達との間に潜在的な関連がある.
研究 の 目的:
- 非流行性単純なの遺伝的基礎を調査する.
- 疾患に関連する特定の遺伝子変異を特定するために.
主な方法:
- 単純な臓病に罹患した3つの家族の遺伝分析.
- タイログロブリン遺伝子のDNAシーケンシング,特にエクソン10のシーケンシング.
主要な成果:
- 56人の家族のうち25人のチログロブリン遺伝子のエクソン10でミッセンスの変異が確認されました.
- この変異は,グルタミンとヒスティジンの置換であり,単純なを患った14人の個人に存在していました.
- 特定された突然変異は,チログロブリン位置に位置していました.
結論:
- タイログロブリン遺伝子の特定の突然変異は,非流行性単純なのいくつかの症例と関連しています.
- この発見は,甲状腺の膨張の背後にある分子メカニズムについての洞察を提供します.
- 甲状腺 globulin の遺伝的欠陥は,甲状腺機能障害に貢献することができます.
関連する概念動画
Mutations
Overview
Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

